Innovator’s Pitch Challenge

Vote for Us

Interested in Connecting? Please contact:
Jeff Haince
General Manager & CSO
jhaince@biomarkdiagnostics.com

Message the company or request a 1:1 meeting here

BioMark Diagnostics (CNSX: BUX, OTCPK: BMKDF) is a Canadian Based company that develops proprietary, non-invasive, and accurate biotechnology and machine learning diagnostics solutions to detect early stage hard to detect and treat cancers. The company’s cancer diagnostics technology is a metabolomics-liquid biopsy based diagnostic assay that allows for cancer detection, monitoring, and prognosis for treatment for cancer in its early stages, where approximately 90% of which can be cured. The company is currently focused on commercialization of its cancer diagnostic assay and detection systems and hopes to start distribution once clinical trials are completed and regulatory acceptance is obtained within the next 12-18 months.

Pitch Video

Slide Deck